-
1.发明申请THE USE OF ADENOSINE UPTAKE INHIBITORS FOR TREATING RETINAL OR OPTIC NERVE HEAD DAMAGE 审中-公开腺嘌呤摄取抑制剂用于治疗神经损伤或神经损伤的使用
公开(公告)号：WO1997018815A2
公开(公告)日：1997-05-29
申请号：PCT/US1996017588
申请日：1996-11-05
Applicant: ALCON LABORATORIES, INC.
Inventor： ALCON LABORATORIES, INC. , SHADE, Debra, L.
IPC: A61K31/505
CPC classification number: A61K31/7076 , A61K31/495 , A61K31/519 , A61K31/522 , A61K31/551 , Y10S514/912
Abstract: Compositions and methods directed to the use of adenosine uptake inhibitors for the treatment of retinal and optic nerve head damage following acute or chronic glaucoma, edema, ischemia, hypoxia or trauma are disclosed.
Abstract translation: 公开了针对使用腺苷摄取抑制剂治疗急性或慢性青光眼，水肿，缺血，缺氧或创伤后视网膜和视神经损伤的组合物和方法。
-
2.发明公开
公开(公告)号：EP1169026A2
公开(公告)日：2002-01-09
申请号：EP00921979.1
申请日：2000-04-07
Applicant: Alcon Laboratories, Inc.
Inventor： SHADE, Debra, L. , PANG, Iok-Hou , CLARK, Abbot, F.
CPC classification number: A61K31/05 , A61K9/0048 , A61K31/353 , A61K31/40
Abstract: Compositions comprising AP-1 activators and methods of use for treating glaucoma and ocular hypertension are disclosed.
-
Search Results
2
records
(took 0.024 seconds)
